Year-End Report 2019
FluoGuide A/S ("FluoGuide") today announces its results for the period 1 January– 31 December 2019. The report is available here .Morten Albrechtsen, CEO of FluoGuide, comments: “I would like to thank all shareholders – new and from the IPO for the strong confidence in our business, our product and us. Together with an extraordinary team, I am looking forward to transform FluoGuide from a pre-clinical company into a phase III company with a pipeline of indications and products during 2021 - a very exciting year ahead” Fourth quarter 2019 (